Richard Burr: “I think they might use the definition of dangerous, and what I have heard you say is dangerous does not come into play.”

More than 278 therapies have been approved under the accelerated approval pathway over the 30 year history, saving and improving thousands of lives.

I question whether the agreements both passed and proposed reflect a good deal for patients they are designed to serve.

Why did FDA agree, and why did the industry agree to longer review times of 128 days on 510(k)'s and provide the agency with so much more money?

I was surprised and frustrated to hear that these funds were overwhelmingly repurposed from within ASPR, including the stockpile.